GeneDx Holdings WGS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$77.81M-270% | -$21.02M— | —— | —— | —— | ||
| $26.36M+4.5% | $25.22M+5.5% | $23.9M+2.3% | $23.36M+4.3% | $22.38M+2.0% | ||
| $37.18M+15.6% | $32.16M+27.5% | $25.23M+38.0% | $18.28M+34.7% | $13.57M+48.5% | ||
| —— | —— | —— | —— | $186K+154% | ||
| —— | —— | —— | —— | $0— | ||
| $30.23M-16.6% | $36.23M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $3.44M+8.8% | $3.16M+4.4% | $3.03M+3.2% | $2.94M-7.0% | $3.16M-3.9% | ||
| —— | —— | —— | —— | —— | ||
| -$6.22M-117% | $36.37M+9.6% | $33.19M+155% | $13.02M+785% | -$1.9M+93.3% | ||
| $19.34M+1.7% | $19.02M+7.3% | $17.72M+45.3% | $12.19M+9.1% | $11.18M+104% | ||
| $2.94M+42.4% | $2.06M+68,633% | $3K— | —— | —— | ||
| -$69.36M-12.8% | -$61.52M-20.7% | -$50.96M+5.7% | -$54.03M-33.8% | -$40.38M-34.0% | ||
| —— | —— | —— | —— | —— | ||
| $2.5M+23.5% | $2.02M+79.1% | $1.13M+9.3% | $1.03M+179% | $370K-6.1% | ||
| $2.34M-4.7% | $2.45M-25.8% | $3.3M+13.9% | $2.9M+0.8% | $2.88M+5.5% | ||
| $72.9M+51.8% | $48.03M-14.0% | $55.86M-5.4% | $59.06M+1.3% | $58.32M+32.1% | ||
| -$5.78M-129% | $19.79M— | —— | —— | —— | ||
| $6.56M+2.3% | $6.41M-1.0% | $6.48M+10.6% | $5.85M-6.5% | $6.26M-6.3% | ||
| $1.82M+43.0% | $1.28M-1.6% | $1.3M-15.3% | $1.53M+42.6% | $1.07M-8.1% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $38.54M-12.3% | $43.97M-12.2% | $50.06M-15.2% | $59.05M+20.2% | $49.14M+19.7% | ||
| $2.94M+42.4% | $2.06M+68,633% | $3K— | —— | —— | ||
| $2.34M-4.7% | $2.45M-25.8% | $3.3M+13.9% | $2.9M+0.8% | $2.88M+5.5% | ||
| $129.94M+177% | $46.83M-18.7% | $57.6M-4.6% | $60.39M0.0% | $60.39M+29.9% | ||
| —— | —— | —— | $7.86M+64.7% | $4.77M+82.7% | ||
| —— | —— | $4.3M+142% | $1.78M-78.7% | $8.37M-37.4% | ||
| —— | —— | —— | —— | $0— | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | —— | $15.47M+1,763% | $830K+106% | -$13.08M+61.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does GeneDx Holdings generate?
- GeneDx Holdings (WGS) generated -$6.2M in operating cash flow over the trailing twelve months.
- What is GeneDx Holdings's free cash flow?
- After $19.3M of capital expenditures, GeneDx Holdings's free cash flow was -$17.2M over the trailing twelve months, up 49.5% year over year.
- Where does GeneDx Holdings's cash flow data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
